Body composition does not affect serum levels of cathelicidin LL-37 in elderly women with unipolar depression

References

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504.
   PubMed Web of Science ®Google Scholar
• Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry. 1999;174:307–311.
   PubMed Web of Science ®Google Scholar
• Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49:837–845.
   PubMed Web of Science ®Google Scholar
• Choi KY, Chow LN, Mookherjee N. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J Innate Immun. 2012;4:361–370.
   PubMed Web of Science ®Google Scholar
• Hazlett L, Wu M. Defensins in innate immunity. Cell Tissue Res. 2011;343:175–188.
   PubMed Web of Science ®Google Scholar
• Hemshekhar M, Anaparti V, Mookherjee N. Functions of cationic host defense peptides in immunity. Pharmaceuticals (Basel). 2016;9:40.
   PubMedGoogle Scholar
• Kahlenberg JM, Kaplan MJ. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol. 2013;191:4895–4901.
   PubMed Web of Science ®Google Scholar
• Vandamme D, Landuyt B, Luyten W, et al. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280:22–35.
   PubMed Web of Science ®Google Scholar
• Tjabringa GS, Ninaber DK, Drijfhout JW, et al. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol. 2006;140:103–112.
   PubMed Web of Science ®Google Scholar
• Nagaoka I, Tamura H, Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol. 2006;176:3044–3052.
   PubMed Web of Science ®Google Scholar
• De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192:1069–1074.
   PubMed Web of Science ®Google Scholar
• Babolewska E, Brzezinska-Blaszczyk E. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response. Cell Immunol. 2015;293:67–73.
   PubMed Web of Science ®Google Scholar
• Wuerth K, Hancock RE. New insights into cathelicidin modulation of adaptive immunity. Eur J Immunol. 2011;41:2817–2819.
   PubMed Web of Science ®Google Scholar
• Kozlowska E, Wysokinski A, Brzezinska-Blaszczyk E. Serum levels of peptide cathelicidin LL-37 in elderly patients with depression. Psychiatry Res. 2017;255:156–160.
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.
   PubMed Web of Science ®Google Scholar
• Aronne LJ, Segal KR. Weight gain in the treatment of mood disorders. J Clin Psychiatry. 2003;64(Suppl 8):22–29.
   PubMed Web of Science ®Google Scholar
• Chmelar J, Chung KJ, Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb Haemost. 2013;109:399–406.
   PubMed Web of Science ®Google Scholar
• Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–2391.
   PubMed Web of Science ®Google Scholar
• Marc LG, Raue PJ, Bruce ML. Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population. Am J Geriatr Psychiatry. 2008;16:914–921.
   PubMed Web of Science ®Google Scholar
• Momeni M, Ghorban K, Dadmanesh M, et al. ASC provides a potential link between depression and inflammatory disorders: a clinical study of depressed Iranian medical students. Nord J Psychiatry. 2016;70:280–284.
   PubMed Web of Science ®Google Scholar
• Ekinci O, Ekinci A. The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio. Nord J Psychiatry. 2017 [Aug 11]; [7 pages]. DOI: 10.1080/08039488.2017.1363285
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, de Courten MP, Stojanovska L, et al. The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res. 2016;60:43–57.
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141–150.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Curiel I, Castaneda-Delgado J, Lopez-Lopez N, et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol. 2011;72:656–662.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Jiang L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med. 2015;9:11–16.
   PubMed Web of Science ®Google Scholar
• Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013;74:31–37.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078.
   PubMed Web of Science ®Google Scholar
• Hoang-Yen Tran D, Hoang-Ngoc Tran D, Mattai SA, et al. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor. Int J Obes Relat Metab Disord. 2016;40:1424–1434.
   Web of Science ®Google Scholar
• Benachour H, Zaiou M, Samara A, et al. Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors. Nutr Metab Cardiovasc Dis. 2009;19:720–728.
   PubMed Web of Science ®Google Scholar
• Lopez-Bermejo A, Chico-Julia B, Castro A, et al. Alpha defensins 1, 2, and 3: potential roles in dyslipidemia and vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 2007;27:1166–1171.
   PubMed Web of Science ®Google Scholar
• Srivastava MD, Thomas A, Srivastava BI, et al. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma. 2007;48:1610–1617.
   PubMed Web of Science ®Google Scholar
• Cakir E, Torun E, Gedik AH, et al. Cathelicidin and human beta-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2014;18:671–675.
   PubMed Web of Science ®Google Scholar
• Yamshchikov AV, Kurbatova EV, Kumari M, et al. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr. 2010;92:603–611.
   PubMed Web of Science ®Google Scholar